TVGN
Semper Paratus Acquisition Corp.
NASDAQ · Healthcare · Biotechnology · US
$7.10
+0.42%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$2.56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.52
- EPS estimate
- -$2.53
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +37.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$2.53 | -$1.52 | Beat 39.92% | — |
| May 15, 2026 | -$2.64 | -$1.61 | Beat 39.02% | — |
| Mar 31, 2026 | -$1.50 | -$1.20 | Beat 20.00% | — |
| Nov 14, 2025 | -$0.06 | -$0.03 | Beat 50.66% | — |
| Aug 19, 2025 | -$0.05 | -$0.03 | Beat 40.00% | — |
| Apr 2, 2025 | -$0.03 | -$0.05 | Miss -56.06% | $396.6K |
| Nov 19, 2024 | — | -$0.03 | — | — |
| Aug 14, 2024 | — | -$0.06 | — | — |
| May 27, 2024 | — | $0.08 | — | — |
| Dec 30, 2023 | — | -$0.01 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026